Search results
In shocking litmus test, FBI security inquiry tried to unmask employee’s Trump support, memos show
Just the News· 3 days agoFBI officials conducting a top-secret security clearance review for a longtime employee asked witnesses whether that employee was known to support former President Donald Trump, if he had expressed ...
Moderna's MMA candidate nabs spot in FDA pilot for rare disease drugs
FierceBiotech· 6 days agoModerna’s methylmalonic acidemia candidate, mRNA-3705, will be developed under the FDA’s START pilot...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 3 days agoHere's why the biotech stock is a no-brainer buy right now. At an inflection point It's no exaggeration to say that Moderna is at an inflection point. The company's previous success stemmed ...
FDA Roundup: June 7, 2024
The Pilot News· 6 days agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID ...
FDA Roundup: June 7, 2024
Morning Times· 6 days agoToday, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID ...
How $4 billion funded the unprecedented COVID-19 pandemic response
Medical Xpress· 6 days agoThe UVA Health researchers used advanced "machine learning"—a form of artificial intelligence—to analyze the thousands of scientific publications that resulted from the National Institutes of ...
6 San Diego scientists elected to National Academy of Sciences, embellishing the region’s standing...
U-T San Diego· 6 days agoSix San Diego researchers have been elected to the National Academy of Sciences, the elite honorary society whose members have included such luminaries as Robert Oppenheimer and Marie Curie.
No, HIPAA does not protect all of your private medical information
KTHV Little Rock· 1 day agoHIPAA has been a major topic of conversation over the past few years, especially as it relates to...
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 3 days agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Things You Should Know About Adenoviruses
Forbes· 1 day agoIn an era where medical innovation is paramount, adenovirus gene therapy is a beacon of hope, offering new avenues for combating genetic disorders...
